Published in Gene Therapy Weekly, May 6th, 2004
"149Pm-. 166Ho-, and 177Lu-DOTA-biotin were pretargeted to LS174T colorectal tumors in nude mice with CC49 scFvSA antibody-streptavidin fusion protein," in a study conducted by M.R. Lewis and colleagues at the University of Missouri.
"Tumor uptakes of 149Pm (22.9% ID/g), 166Ho (30.2% ID/g),...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.